Antiallergic agents from natural sources 9. Inhibition of nitric oxide production by novel chalcone derivatives from Mallotus philippinensis (Euphorbiaceae)

Chemical and Pharmaceutical Bulletin

Volumn 52, Issue 11, 2004, Pages 1326-1329

  Daikonya, Akihiro ^a   Katsuki, Shigeki ^b   Kitanaka, Susumu ^a  

^a NIHON UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Chalcone; Euphorbiaceae; Mallotus philippinensis; Nitric oxide

Indexed keywords

CHALCONE DERIVATIVE; CYCLOOXYGENASE 2; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; KAMALA EXTRACT; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PLANT EXTRACT; RECOMBINANT GAMMA INTERFERON; UNCLASSIFIED DRUG; ANTIALLERGIC AGENT;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG SYNTHESIS; GENE EXPRESSION; MACROPHAGE; NONHUMAN; BIOSYNTHESIS; CHEMISTRY; DRUG ANTAGONISM; ISOLATION AND PURIFICATION; MALLOTUS PHILIPPINENSIS;

ANTI-ALLERGIC AGENTS; CHALCONES; MALLOTUS PLANT; NITRIC OXIDE; PLANT EXTRACTS;

EID: 20344402268     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.52.1326     Document Type: Article

References (16)

1. Part 9 in the series on the contents. Part 8: Motai T., Kitanaka S., Chem. Pharm. Bull., 52, 1215-1218 (2004).
2. Tanaka T. A., Ito T., Iinuma M., Takahashi Y., Naganawa H., Phytochemistry, 48, 1423-1427 (1998).
3. Daikonya A., Katsuki S., Wu J. B., Kitanaka S., Chem. Pharm. Bull., 50, 1566-1569 (2002).
4. Lounasmaa M., Widen C. L., Tuuf C. M., Huhtikangas A., Planta Med., 28, 16-31 (1975).
5. Ahluwalia V. K., Sharma N. D., Mittal B., Gupta S. R., Ind. J. Chem., 27B, 238-241 (1988).
6. Satyavati G. V., Gupta K. A., Tandon N., Medicinal Plants of India, 2, 201 (1987).
7. Adams D. O., Hamilton T. A., Annu. Rev. Immunol., 2, 283-318 (1984).
8. Bonta I. L., Ben-Efraim S., J. Leukocyte Biol., 54, 613-626 (1993).
9. Lee S. H., Soyoola E., Chanmugam P., Hart S., Sun W., Zhong H., Liou S., Simmons D., Hwang D., J. Biol. Chem., 267, 25934-25938 (1992).
10. Moncada S., Palmer R. M., Higgs E. A., Pharmacol. Rev., 43, 109-142 (1991).
11. Marletta M. A., Yoon P. S., Iyengar R., Leaf C. D., Wishnok J. S., Biochemistry, 27, 8706-8711 (1988).
12. Manjeet K. R., Ghosh B., Int. J. Immunopharmacol., 21, 435-443 (1999).
13. Connor J. R., Manning P. T., Settle S. L., Moore W. N., Jerome G. M., Webber R. K., Tjoeng F. S., Currie M. G., Eur. J. Pharmacol., 273, 15-24 (1995).
14. Grabowski P. S., England A. J., Dykhuizen R., Copland M., Benjamin N., Reid D. M., Ralston S. H., Arthritis Rheum., 39, 643-647 (1996).
15. Farrell A. J., Blake D. R., Palmer R. M. J., Moncada S., Ann. Rheum. Dis., 51, 1219-1222 (1992).
16. Ishii R., Saito K., Horie M., Shibano T., Kitanaka S., Amano F., Biol. Pharm. Bull., 22, 647-653 (1999).